# A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter

> **NCT01978860** · NA · COMPLETED · sponsor: **Chanan Schneider** · enrollment: 2 (actual)

## Conditions studied

- Chronic Total Occlusion of Coronary Artery

## Interventions

- **DEVICE:** NovaCross, CTO

## Key facts

- **NCT ID:** NCT01978860
- **Lead sponsor:** Chanan Schneider
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978860, "A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01978860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*